(VIR) – Trader Talk
-
Vir Biotechnology (VIR) Stock Sinks 11% as FDA Suspends the Use of Sotrovimab Against COVID-19
-
Vir Biotechnology Inc. (VIR) Falls as FDA Says Sotrovimab no longer authorized to treat COVID-19 in any U.S. region
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to VIR Stock Lookup